亨迪药业：股东雷小艳已减持0.998%

Group 1 - The core point of the announcement is that shareholder Lei Xiaoyan has reduced her stake in Hendi Pharmaceutical by selling 4.1671 million shares at an average price of 14.25 yuan, which represents 0.998% of the company's total share capital [1] - After the reduction, Lei Xiaoyan's holdings decreased to 11.4929 million shares, accounting for 2.752% of the total shares, down from 15.66 million shares, which was 3.75% [1] - The shares sold were from those issued prior to the company's initial public offering, and the reduction plan has expired in compliance with relevant regulations [1]